AMBEV S.A. (ABEV) is a publicly traded Consumer Defensive sector company. As of November 17, 2026, ABEV trades at $2.71 with a market cap of $42.54B and a P/E ratio of 0.00. ABEV moved -0.11% today. Year to date, ABEV is +9.92%; over the trailing twelve months it is +6.47%. Its 52-week range spans $2.10 to $3.45. Analyst consensus is neutral with an average price target of $3.34. Rallies surfaces ABEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ambev Q3 profit tops estimates as board approves 190 million-share buyback: Ambev reported Q3 net profit of R$4.37 billion, down 10.2% year over year but above estimates. Brazil nonalcoholic beverage volumes grew by mid-single digits, and the business’s EBITDA margin expanded 200 basis points in the first nine months; the board also approved repurchases of up to 190 million shares through April 28, 2028.
| Metric | Value |
|---|---|
| Price | $2.71 |
| Market Cap | $42.54B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.01% |
| 52-Week High | $3.45 |
| 52-Week Low | $2.10 |
| Volume | 12.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover ABEV: 0 strong buy, 1 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.34.